Inlecitug
Product Specifications
CAS Number
2997627-68-4
Target
VEGFR
Related Pathways
Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
Inlecitug is a chimeric monoclonal antibody that targets the human KDR (kinase insert domain receptor) . By specifically binding to KDR, Inlecitug blocks the interaction between vascular endothelial growth factor (VEGF) and KDR, thereby inhibiting angiogenesis and exerting antitumor activity. Inlecitug holds potential for cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
